|
The
Elizabeth Taylor AIDS Foundation (ETAF) announced today
its third annual New York Dinner, hosted by renowned
journalist Don Lemon, will take place on May 8, 2025 at the
legendary Rainbow Room on the 65th floor of Rockefeller
Plaza.
Generously supported by Presenting Sponsor
Gilead Sciences, Inc., Oscar, Golden Globe and
Emmy-nominated actress and choreographer Rosie Perez will be
honored with The Elizabeth Taylor Legacy Award. Perez is a
longtime AIDS activist and served on the Presidential
Advisory Council on HIV/AIDS (PACHA) appointed by President
Barack Obama. In addition, Perez is a long-term supporter of
ETAF LIFEBEAT.
Producer and longtime HIV/AIDS advocate Gary
Dell’Abate will be honored with The Elizabeth Taylor
Commitment to End AIDS Award. LIFEBEAT has been a passion
for Dell’Abate, having been actively involved for more than
30 years, and he serves on the Advisory Board of ETAF
LIFEBEAT.
The New York Dinner, which will feature an
intimate reception, seated dinner and program, and live
performance, is one of the most visible annual events for
ETAF. The proceeds from the evening will continue the work
toward Elizabeth Taylor’s vision of a world
free of AIDS.
For more information, please contact
info@etaf.org
ABOUT ETAF
Working tirelessly on the AIDS crisis
throughout the 1980s, Elizabeth Taylor established The
Elizabeth Taylor AIDS Foundation (ETAF) in 1991 to carry out
her vision for an AIDS-free world. ETAF works to provide the
direct care needed for people living with and affected by
HIV and AIDS. Emphasizing Elizabeth's voice, commitment, and
concentration on hard-to-reach communities, ETAF's domestic
advocacy initiatives remain a priority. Fighting for
criminalization reform for people living with HIV, ETAF’s
primary advocacy initiative, “HIV Is Not A Crime” fights for
not only the elimination of criminalization, but also stigma
and discrimination. ETAF's programs have also expanded to
ensure that HIV prevention education and access to treatment
are available through domestic and international
initiatives.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical
company that has pursued and achieved breakthroughs in
medicine for more than three decades, with the goal of
creating a healthier world for all people. The company is
committed to advancing innovative medicines to prevent and
treat life-threatening diseases, including HIV, viral
hepatitis, COVID-19, cancer, and inflammation. Gilead
operates in more than 35 countries worldwide, with
headquarters in Foster City, Calif.
|